The Genuine Facts Supporting the White House’s Promotion of the New COVID Vaccines
What if I told you that one in 50 people who took a new medication experienced a “medically attended adverse event,” and the manufacturer refused to disclose the nature of the complication? Would you still be willing to take it? And what if the potential benefits only lasted for three months, after which your susceptibility returned to normal? Additionally, what if I informed you that the Food and Drug Administration (FDA) approved this medication without any human-outcomes data, and European regulators are not universally recommending it like the Centers for Disease Control and Prevention (CDC) are? These are the facts we currently know about the new COVID vaccine that the Biden administration is strongly recommending for all Americans aged 6 months and older.
The push for this vaccine is so forceful that former White House COVID coordinator Ashish Jha and CDC head Mandy Cohen are making unsupported claims about its ability to reduce hospitalizations, long COVID, and the likelihood of spreading COVID. None of these claims have any scientific evidence to support them. In fact, if the manufacturers were to make such claims, they could be fined for making false marketing statements that go beyond the FDA’s approved usage indication.
There are still many questions surrounding Moderna’s recently approved COVID vaccine. One in every 50 Americans has experienced complications from the COVID-19 vaccine. Pfizer’s version, which was also approved recently, has no efficacy data and has not been tested on humans at all. We only have data about antibody production from 10 mice. The FDA, or Moderna, should disclose information about the patient who experienced a complication requiring medical attention after receiving the new vaccine. The public has a right to know.
Last fall, the Biden administration approved and recommended a novel COVID bivalent booster without any human outcome data, and it was a failure. Only 17% of Americans took it, and some were forced to do so by their employer or school. Despite this weak public support, the Biden administration had already pre-paid pharmaceutical companies $4.9 billion for 171 million doses, many of which ended up going to waste. Now, they are repeating the same mistake. Just two weeks ago, the Biden administration increased its orders for pediatric doses of the new COVID vaccine, spending $1.7 billion for 20 million doses, over four times as many as were used last year. There seems to be a significant push to administer this vaccine to children, even though European regulators do not support it. In fact, the original Moderna vaccine was banned in parts of Europe for people under the age of 30. European doctors are not alone in their concerns. Dr. Paul Offit, a vaccine-mandate supporter and FDA adviser, has stated that he will not be taking the new COVID vaccine. He did not take the bivalent booster last fall either, despite being 72 years old.
It is clear that there is a concerted effort to give the new COVID vaccine to children, even though European regulators do not recommend it. The original Moderna vaccine was banned in parts of Europe for people under the age of 30. It’s not just European doctors who have concerns; Dr. Paul Offit, a vaccine-mandate advocate and FDA adviser, has stated that he will not be taking the new COVID vaccine. He also did not take the bivalent booster last fall, despite being 72 years old. Unlike influenza vaccines, COVID vaccines have higher complication rates, including severe and life-threatening cardiac reactions. COVID vaccines have been associated with a serious adverse event rate of one in 5,000 doses, according to a German study. Another study estimated the rate of serious adverse events to be as high as one in 556 COVID-vaccine recipients. In young people, the incidence of myocarditis is six to 28 times higher after the vaccine than after infection, according to a study published in JAMA Cardiology.
Furthermore, some scientists are worried about immune imprinting and the potential weakening of the immune system from multiple booster doses. A study published in Science described reduced immune response in people who were infected with COVID and then received three vaccine doses.
If the new COVID vaccine is to be widely accepted and effective, a proper clinical trial should be conducted to demonstrate its benefits. Public health officials cannot continue to ignore the scientific method and our regulatory process. It is time for the FDA to resume its role as a regulator and not as a marketing department for pharmaceutical companies. The CDC’s recommendation also ignores natural immunity, which has been found to be at least as good, if not better, than vaccinated immunity in several studies.
If public health officials want a better turnout for the COVID booster shot, they should require a proper clinical trial to demonstrate its benefits. They should not waste any more credibility and money on interventions that lack scientific support. It is crucial to prioritize the scientific process and ensure that the American people are provided with accurate and transparent information.
Source link
